跳至主要内容
临床试验/EUCTR2017-004187-35-SE
EUCTR2017-004187-35-SE进行中(未招募)1 期

The FACE (Facial nerve palsy And Cortisone Evaluation) study in children: a randomised double-blind, placebo-controlled, multicenter trial.

Falun Hospital0 个研究点目标入组 500 人开始时间: 2018年10月31日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.1-17 years of age
  • 2.Acute peripheral facial nerve palsy
  • 3.Less than 72 hours of duration of symptoms
  • 4.Signed informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 500
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 2.Central facial nerve palsy
  • 3.Malformations in head and neck
  • 4.Conditions not compatible with cortisone treatment (hypertension, diabetes mellitus type 1, psychiatric disorder, active or latent tuberculosis, intolerance of lactose)
  • 5.Current or past oncological diagnosis
  • 6.Other serious medical conditions (meningitis, encephalitis, stroke)
  • 7.Acute otitis media
  • 8.Signs of herpes simplex or varicella zoster infection (vesicles in the ear region)
  • 9.Pregnancy or breastfeeding
  • 10.Use of any systemic or inhaled steroids within 2 weeks prior onset of symptoms
  • 11.Immunization with live vaccine 1 month prior onset of symptoms
  • 12.Requirement of live vaccine within 2 months from start of experimental treatment (prednisolone or placebo)
  • 13.Evaluation of primary endpoint at 12 months not feasible for any reason
  • 14.Previously included into the FACE study

研究者

发起方
Falun Hospital

相似试验